Skip to content

The archive

Medical & Historical

The medical and historical background to the infected blood scandal, including HIV, hepatitis, blood products, transfusions, treatment history and the evidence that explains how the disaster unfolded.

Latest in Medical & Historical

A stack of ageing medical records stamped “MISSING” sits beside a red confidential folder and a stethoscope in a darkened room, symbolising the missing evidence faced by families affected by the infected blood scandal.
Medical & Historical

IBCA Finally Acknowledges Missing Evidence — But What About the Families Left Behind?

A new IBCA policy recognises that some deceased victims' hepatitis C infections can be accepted without direct diagnostic evidence. But after decades of missing medical records, destroyed evidence and families fighting to establish the truth, serious questions remain. Why has this recognition taken so long, why are strict cut-off dates being applied, and what happens to the families who still fall outside the rules?

Read story
Medical & Historical

What Was the Infected Blood Scandal?

For decades, people across the UK were infected with HIV, hepatitis B and hepatitis C through contaminated blood and blood products provided through the NHS. The public inquiry that examined what happened found serious and largely avoidable failures across blood services, treatment, government and healthcare.

Read story
Medical & Historical

Was Britain’s Infected Blood Scandal Really About American Blood?

The infected blood scandal is often described as Britain importing contaminated blood from America. But that shorthand can hide a much more complicated story involving plasma, clotting-factor concentrates, UK self-sufficiency failures and decisions taken here. We went back to the Infected Blood Inquiry evidence to separate the facts from the familiar narrative.

Read story
Medical & Historical

The Test That Came Too Late: Why Hepatitis B Must Never Be Treated as the “Lesser” Infection

Previously unseen medical records reveal that a haemophiliac infected through NHS treatment was not diagnosed with hepatitis B until routine testing in 1990. A later consultant’s letter said his notes suggested he had never previously been tested. Within two years, his records described chronic liver disease and a high risk of infectivity. By 1999, he had jaundice, portal hypertension and underlying cirrhosis. He died in January 2000, aged just 38. His records cannot tell us what earlier testing would ultimately have changed. But they expose why hepatitis B testing, monitoring and recognition matter—and why this infection must never be dismissed as minor simply because it can sometimes clear naturally.

Read story
Medical & Historical

AZT and Interferon: How Does Compensation Recognise the Harm of Treatment?

People infected through NHS blood and blood products could face further suffering from the treatments they received. With clearer recognition now given to interferon, we examine how the scheme accounts for early HIV treatment—and whether it adequately recognises these different experiences, without placing one person’s suffering above another’s.

Read story